Company: NCEL
Filing Date: 2025-07-18
Form Type: 425
Source: 0001213900-25-065658
Chunk: 6

Company: NewcelX Ltd.
Filing Date: 2025-07-18
Form: 425
Chunk 6
---
 any documents that may be reasonably
necessary to carry out the provisions of this Amendment.

6. . Except to the extent that the Applicable Laws of the State of Israel apply in respect of the procedural aspects of the Merger
as set forth in ‎Article I of the Agreement, this Amendment shall be governed by, and construed in accordance with, the laws of the
State of Delaware, without regard to any rule or principle that might refer the governance or construction of this Amendment to the Laws
of another jurisdiction.

7. .
This Amendment may be executed in separate counterparts, each of such counterparts shall for all purposes be deemed to be original and
all such counterparts shall together constitute but one and the same instrument.

<div align='center'>[Remainder of Page Left Blank Intentionally; Signature Page Follows Immediately.]

3</div>

IN WITNESS WHEREOF, the parties hereto have caused
this Amendment to be duly executed by their respective authorized signatories as of the date first indicated above.

| NLS PHARMACEUTICS LTD.          |                         |
| By:                             | /s/ Alexander C. Zwyer  |
| Name:                           | Alexander C. Zwyer      |
| Title:                          | Chief Executive Officer |
| By:                             | /s/ Ronald Hafner       |
| Name:                           | Ronald Hafner           |
| Title:                          | Chairman of the Board   |
| NLS PHARMACEUTICS (ISRAEL) LTD. |                         |
| By:                             | /s/ Kobi Maimon         |
| Name:                           | Kobi Maimon             |
| Title:                          | Director                |
| KADIMASTEM LTD.                 |                         |
| By:                             | /s/ Ronen Twito         |
| Name:                           | Ronen Twito             |
| Title:                          | Chief Executive Officer |